Kazimierz O. Wrzeszczynski, Ph.D. - Publications

Affiliations: 
2009 Columbia University, New York, NY 
Area:
Bioinformatics Biology, Biochemistry

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Woods AD, Purohit R, Mitchell L, Collier J, Collier K, Lathara M, Learned K, Vaske O, Geiger H, Wrzeszczynski KO, Jobanputra V, Srinivasa G, Rudzinski E, Whelan K, Beierle E, et al. Metastatic Pediatric Sclerosing Epithelioid Fibrosarcoma. Cold Spring Harbor Molecular Case Studies. PMID 34362827 DOI: 10.1101/mcs.a006093  1
2021 Jobanputra V, Wrzeszczynski KO, Buttner R, Caldas C, Cuppen E, Grimmond S, Haferlach T, Mullighan C, Schuh A, Elemento O. Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology. Seminars in Cancer Biology. PMID 34256129 DOI: 10.1016/j.semcancer.2021.07.003  1
2021 Meggendorfer M, Jobanputra V, Wrzeszczynski KO, Roepman P, de Bruijn E, Cuppen E, Buttner R, Caldas C, Grimmond S, Mullighan CG, Elemento O, Rosenquist R, Schuh A, Haferlach T. Analytical demands to use whole-genome sequencing in precision oncology. Seminars in Cancer Biology. PMID 34119643 DOI: 10.1016/j.semcancer.2021.06.009  1
2019 Wrzeszczynski KO, Rahman S, Frank MO, Arora K, Shah M, Geiger H, Felice V, Manaa D, Dikoglu E, Khaira D, Chimpiri AR, Michelini VV, Jobanputra V, Darnell RB, Powers S, et al. Identification of targetable BRAF ΔN486_P490 variant by whole genome sequencing leading to dabrafenib-induced remission of a BRAF-mutant pancreatic adenocarcinoma. Cold Spring Harbor Molecular Case Studies. PMID 31519698 DOI: 10.1101/mcs.a004424  1
2019 Frank MO, Koyama T, Rhrissorrakrai K, Robine N, Utro F, Emde AK, Chen BJ, Arora K, Shah M, Geiger H, Felice V, Dikoglu E, Rahman S, Fang X, Vacic V, ... ... Wrzeszczynski KO, et al. Correction to: Sequencing and curation strategies for identifying candidate glioblastoma treatments. Bmc Medical Genomics. 12: 114. PMID 31375115 DOI: 10.1186/S12920-019-0563-Y  1
2019 Frank MO, Koyama T, Rhrissorrakrai K, Robine N, Utro F, Emde AK, Chen BJ, Arora K, Shah M, Geiger H, Felice V, Dikoglu E, Rahman S, Fang A, Vacic V, ... ... Wrzeszczynski KO, et al. Sequencing and curation strategies for identifying candidate glioblastoma treatments. Bmc Medical Genomics. 12: 56. PMID 31023376 DOI: 10.1186/S12920-019-0500-0  1
2018 Diolaiti D, Dela Cruz FS, Gundem G, Bouvier N, Boulad M, Zhang Y, Chou AJ, Dunkel IJ, Sanghvi R, Shah M, Geiger H, Rahman S, Felice V, Wrzeszczynski KO, Darnell RB, et al. A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high grade spindle cell sarcoma. Cold Spring Harbor Molecular Case Studies. PMID 30552129 DOI: 10.1101/mcs.a003194  1
2018 Wrzeszczynski KO, Felice V, Abhyankar A, Kozon L, Geiger H, Manaa D, London F, Robinson D, Fang X, Lin D, Lamendola-Essel MF, Khaira D, Dikoglu E, Emde AK, Robine N, et al. Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient Derived Tumors Clinical Application of Whole-Genome Sequencing for Reporting Targetable Variants in Cancer. The Journal of Molecular Diagnostics : Jmd. PMID 30138725 DOI: 10.1016/J.Jmoldx.2018.06.007  1
2018 Wrzeszczynski KO, Felice V, Shah M, Rahman S, Emde AK, Jobanputra V, O Frank M, Darnell RB. Whole Genome Sequencing-Based Discovery of Structural Variants in Glioblastoma. Methods in Molecular Biology (Clifton, N.J.). 1741: 1-29. PMID 29392687 DOI: 10.1007/978-1-4939-7659-1_1  1
2017 Basturk O, Berger MF, Yamaguchi H, Adsay V, Askan G, Bhanot UK, Zehir A, Carneiro F, Hong SM, Zamboni G, Dikoglu E, Jobanputra V, Wrzeszczynski KO, Balci S, Allen P, et al. Pancreatic intraductal tubulopapillary neoplasm is genetically distinct from intraductal papillary mucinous neoplasm and ductal adenocarcinoma. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 28776573 DOI: 10.1038/modpathol.2017.60  1
2017 Wrzeszczynski KO, Frank MO, Koyama T, Rhrissorrakrai K, Robine N, Utro F, Emde AK, Chen BJ, Arora K, Shah M, Vacic V, Norel R, Bilal E, Bergmann EA, Moore Vogel JL, et al. Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma. Neurology. Genetics. 3: e164. PMID 28740869 DOI: 10.1212/Nxg.0000000000000164  1
2016 Basturk O, Tan M, Bhanot U, Allen P, Adsay V, Scott SN, Shah R, Berger MF, Askan G, Dikoglu E, Jobanputra V, Wrzeszczynski KO, Sigel C, Iacobuzio-Donahue C, Klimstra DS. The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27282351 DOI: 10.1038/modpathol.2016.98  1
2015 Fan G, Wrzeszczynski KO, Fu C, Su G, Pappin DJ, Lucito R, Tonks NK. A quantitative proteomics-based signature of platinum sensitivity in ovarian cancer cell lines. The Biochemical Journal. 465: 433-42. PMID 25406946 DOI: 10.1042/Bj20141087  1
2013 Wrzeszczynski KO, Varadan V, Kamalakaran S, Levine DA, Dimitrova N, Lucito R. Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer. Methods in Molecular Biology (Clifton, N.J.). 1049: 35-51. PMID 23913207 DOI: 10.1007/978-1-62703-547-7_4  1
2013 Lum E, Vigliotti M, Banerjee N, Cutter N, Wrzeszczynski KO, Khan S, Kamalakaran S, Levine DA, Dimitrova N, Lucito R. Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis. Gynecologic Oncology. 130: 369-76. PMID 23684582 DOI: 10.1016/J.Ygyno.2013.05.002  1
2011 Wrzeszczynski KO, Varadan V, Byrnes J, Lum E, Kamalakaran S, Levine DA, Dimitrova N, Zhang MQ, Lucito R. Identification of tumor suppressors and oncogenes from genomic and epigenetic features in ovarian cancer. Plos One. 6: e28503. PMID 22174824 DOI: 10.1371/Journal.Pone.0028503  1
2011 Cheng J, Zhu Y, He S, Lu Y, Chen J, Han B, Petrillo M, Wrzeszczynski KO, Yang S, Dai P, Zhai S, Han D, Zhang MQ, Li W, Liu X, et al. Functional mutation of SMAC/DIABLO, encoding a mitochondrial proapoptotic protein, causes human progressive hearing loss DFNA64. American Journal of Human Genetics. 89: 56-66. PMID 21722859 DOI: 10.1016/J.Ajhg.2011.05.027  1
2009 Wrzeszczynski KO, Rost B. Cell cycle kinases predicted from conserved biophysical properties. Proteins. 74: 655-68. PMID 18704950 DOI: 10.1002/Prot.22181  1
2008 Soong TT, Wrzeszczynski KO, Rost B. Physical protein-protein interactions predicted from microarrays. Bioinformatics (Oxford, England). 24: 2608-14. PMID 18829707 DOI: 10.1093/Bioinformatics/Btn498  1
2008 Rost B, Liu J, Przybylski D, Nair R, Wrzeszczynski KO, Bigelow H, Ofran Y. Prediction of Protein Structure Through Evolution Handbook of Chemoinformatics. 4: 1789-1811. DOI: 10.1002/9783527618279.ch45b  1
2004 Wrzeszczynski KO, Rost B. Annotating proteins from endoplasmic reticulum and Golgi apparatus in eukaryotic proteomes. Cellular and Molecular Life Sciences : Cmls. 61: 1341-53. PMID 15170512 DOI: 10.1007/S00018-004-4005-3  0.6
2004 Wrzeszczynski KO, Rost B. Cataloging proteins in cell cycle control. Methods in Molecular Biology (Clifton, N.J.). 241: 219-33. PMID 14970657 DOI: 10.1385/1-59259-646-0:219  1
Show low-probability matches.